Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa
about
Genital ulcer disease treatment for reducing sexual acquisition of HIVInfectious co-factors in HIV-1 transmission herpes simplex virus type-2 and HIV-1: new insights and interventionsThe Role of Sexually Transmitted Infections in HIV-1 Progression: A Comprehensive Review of the LiteratureReview: [corrected] The changing face of the HIV epidemic in sub-Saharan AfricaIntegrating prevention interventions for people living with HIV into care and treatment programs: a systematic review of the evidence.A multi-targeted drug candidate with dual anti-HIV and anti-HSV activityEffects of valacyclovir on markers of disease progression in postpartum women co-infected with HIV-1 and herpes simplex virus-2Episodic therapy for genital herpes in sub-saharan Africa: a pooled analysis from three randomized controlled trials.Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study.A new class of dual-targeted antivirals: monophosphorylated acyclovir prodrug derivatives suppress both human immunodeficiency virus type 1 and herpes simplex virus type 2Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk.Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.Conformational analysis, molecular structure and solid state simulation of the antiviral drug acyclovir (zovirax) using density functional theory methods.Correlates of HIV-1 genital shedding in Tanzanian women.Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.Herpes simplex virus type 2, genital ulcers and HIV-1 disease progression in postpartum women.Long-term impact of acyclovir suppressive therapy on genital and plasma HIV RNA in Tanzanian women: a randomized controlled trial.Can we reduce the spread of HIV infection by suppressing herpes simplex virus type 2 infection?The Interplay between Sexually Transmitted Infections and HIV: An Evolving StoryHerpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected persons.Effect of genital herpes on cervicovaginal HIV shedding in women co-infected with HIV AND HSV-2 in Tanzania.Genital HSV detection among HIV-1-infected pregnant women in labor.Update in HIV medicine for the generalist.Addition of Acyclovir does not affect Adherence to HAART in HIV-1/ HSV-2 Co-Infected Women.Getting research into policy - Herpes simplex virus type-2 (HSV-2) treatment and HIV infection: international guidelines formulation and the case of Ghana.Investing in the future: lessons learnt from communicating the results of HSV/ HIV intervention trials in South AfricaPerformance of the BioPlex 2200 multiplexing immunoassay platform for the detection of herpes simplex virus type 2 specific antibodies in African settings.The role of coinfections in HIV epidemic trajectory and positive prevention: a systematic review and meta-analysisBrief report: HIV-1 transmissions during asymptomatic infection: exploring the impact of changes in HIV-1 viral load due to coinfections.Genital herpes: oral antiviral treatments.Time to refocus on HSV interventions for HIV prevention?The role of co-infections in mother-to-child transmission of HIV.High-dose valacyclovir HSV-2 suppression results in greater reduction in plasma HIV-1 levels compared with standard dose acyclovir among HIV-1/HSV-2 coinfected persons: a randomized, crossover trialInterim modelling analysis to validate reported increases in condom use and assess HIV infections averted among female sex workers and clients in southern India following a targeted HIV prevention programme.Valacyclovir Decreases Plasma HIV-1 RNA in HSV-2 Seronegative Individuals: A Randomized Placebo-Controlled Crossover Trial.Valacyclovir suppressive therapy reduces plasma and breast milk HIV-1 RNA levels during pregnancy and postpartum: a randomized trial.Effect of HSV-2 suppressive therapy on genital tract HIV-1 RNA shedding among women on HAART: a pilot randomized controlled trial.Meta-analysis of randomized trials on the association of prophylactic acyclovir and HIV-1 viral load in individuals coinfected with herpes simplex virus-2.Exploiting the anti-HIV-1 activity of acyclovir: suppression of primary and drug-resistant HIV isolates and potentiation of the activity by ribavirin'It's not about money, it's about my health': determinants of participation and adherence among women in an HIV-HSV2 prevention trial in Johannesburg, South Africa
P2860
Q24201630-0179DEF6-D4F8-4BDE-8D4D-699349BED062Q26823594-657A6A78-93CD-4D95-9DAB-78E73A1E380AQ26864344-D8E7DE09-AC7C-4F34-9252-A9C20246BF24Q27022927-4B0998E0-19C9-46E7-A899-6FD94D17AB9EQ27313271-24508B3A-9796-440B-BD79-956861D85B37Q28534866-B8517F1D-6CB8-4C5F-A5E8-FB4E68D8DF41Q28728582-A642A0D1-CAB5-41BF-8647-EBDF73953677Q31028568-10CA062A-B147-43F1-8E75-4A95E289B1D0Q33436735-10154C87-E9E2-4095-A0D8-2BEBCFE926D5Q33609662-47C8C2EC-20F0-489E-9D96-E3BB7FA308CCQ33697958-7EEBD894-40FA-4FBD-8E84-BB99331BECAAQ33727305-A1F545FF-1BDA-443A-BD30-82C2E23119F1Q33833712-E796E16E-0649-4EC8-9566-44EA988AEDACQ33842085-375331D3-A6D0-4D2B-BE2B-F62CAC7E3B06Q33881449-489AC817-CA2C-442D-8D3A-39C1F0CEDEC0Q33921326-BE5E4A49-0B3A-48DD-8C1D-1DB095839108Q34168234-CADDC5D7-BBEF-4A04-AB65-7BEE65E0635CQ34175582-69DDFD13-5BAE-414F-A099-713C3D7D5358Q34196145-9AEAA413-558D-4D99-95F7-79EE918774F9Q34508433-9A464758-31C6-460F-8D95-1B7F938222F0Q34630266-B10AD69E-22FE-447C-822D-D9983B9AD29EQ34745207-6D647F75-CDD3-4637-94CC-5892C68DA30FQ34799053-C4375947-AC4C-49C3-B36A-27ACBF587B33Q34978073-18712291-8906-4230-9B8A-922D10320668Q35062477-A19D9D0C-0E8B-4441-9A95-FAE63D0219F9Q35062487-8D07ABCE-70D5-4736-B89E-F3D7C3C6DEDBQ35138634-93C2C9FC-F4B9-48D0-B858-0FF0BFB7B5B4Q35149893-8F3452D1-F50C-4B38-BE36-3EF0FAFECEBEQ35288465-A68300DF-FEB0-4133-8113-E28D694D6DFBQ35318973-1EFD9B93-28CA-41D2-8DB1-02835FD79824Q35532849-9D3F09B6-6366-47A1-B14C-C8ED56CDEA61Q35542406-671C318D-70AE-461B-B21A-BACD40ED5426Q35639207-C6103E59-51F8-426D-933A-CFAB3D2967C6Q35656655-8CF8589B-2AC3-4E96-A9CF-F61190E2BED5Q35661728-16274E91-7819-4764-AAB7-061CA2951A0CQ35669036-1690F6D2-386A-4FB8-8DF0-D47193AA796CQ35821254-2FBD0422-7D17-46E4-857B-4469FD872605Q35848836-82FB6042-8249-4C74-B31B-AA2D5FE46340Q35941302-75D4C63A-7A7E-4C27-888B-57AF8E1A25E5Q36194047-804D4013-0716-4E5B-B254-A5E4BDFC0201
P2860
Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Impact of aciclovir on genital ...... ntrolled trial in South Africa
@ast
Impact of aciclovir on genital ...... ntrolled trial in South Africa
@en
Impact of aciclovir on genital ...... ntrolled trial in South Africa
@nl
type
label
Impact of aciclovir on genital ...... ntrolled trial in South Africa
@ast
Impact of aciclovir on genital ...... ntrolled trial in South Africa
@en
Impact of aciclovir on genital ...... ntrolled trial in South Africa
@nl
prefLabel
Impact of aciclovir on genital ...... ntrolled trial in South Africa
@ast
Impact of aciclovir on genital ...... ntrolled trial in South Africa
@en
Impact of aciclovir on genital ...... ntrolled trial in South Africa
@nl
P2093
P2860
P50
P1433
P1476
Impact of aciclovir on genital ...... ntrolled trial in South Africa
@en
P2093
Alexio Capovilla
Godspower Akpomiemie
Helen Rees
Laurent Belec
Nonkululeko Mlaba
Sinéad Delany
Tim Clayton
Wendy Stevens
P2860
P304
P356
10.1097/QAD.0B013E32831DB217
P407
P577
2009-02-01T00:00:00Z